Key Findings

Mutations at position 105 in class A beta-lactamases, such as I105R in blaC, Y105G in ctx-m-14, and Y105G in tem-1, confer resistance to clavulanic acid and avibactam. These mutations alter the enzyme's affinity for inhibitors, leading to reduced susceptibility.